Key Insights

Highlights

Success Rate

71% trial completion

Published Results

11 trials with published results (17%)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 49/100

Termination Rate

12.7%

8 terminated out of 63 trials

Success Rate

71.4%

-15.1% vs benchmark

Late-Stage Pipeline

13%

8 trials in Phase 3/4

Results Transparency

55%

11 of 20 completed with results

Key Signals

11 with results71% success

Data Visualizations

Phase Distribution

53Total
Not Applicable (23)
Early P 1 (3)
P 1 (5)
P 2 (14)
P 3 (3)
P 4 (5)

Trial Status

Completed20
Recruiting16
Terminated8
Withdrawn7
Unknown6
Not Yet Recruiting3

Trial Success Rate

71.4%

Benchmark: 86.6%

Based on 20 completed trials

Clinical Trials (63)

Showing 20 of 20 trials
NCT07752134Phase 1Not Yet RecruitingPrimary

Efficacy and Safety of Pregabalin Combined With Educational and Behavioral Intervention for Bladder Pain Syndrome/Interstitial Cystitis

NCT04734106Early Phase 1Recruiting

Safety and Efficacy of Aloe Vera in the Management of the Symptoms of Interstitial Cystitis

NCT06013449Not ApplicableWithdrawn

Efficacy of Pulsed Electromagnetic Field and Heparin/Bupivacaine Instillations

NCT07698626Phase 1Not Yet RecruitingPrimary

Venlafaxine Combined With Education and Behavioral Intervention for Bladder Pain Syndrome

NCT04450316Phase 2TerminatedPrimary

Low-dose Naltrexone for Bladder Pain Syndrome

NCT06232200Not ApplicableCompleted

Investigation of the Effectiveness of Acupuncture in Patients Diagnosed With Interstitial Cystitis

NCT04734847Not ApplicableActive Not Recruiting

Motor Cortical Neuromodulation in Women With Interstitial Cystitis/Bladder Pain Syndrome

NCT05149573Not ApplicableRecruiting

Investigation of PEMF Therapy for Female Patients With IC/BPS

NCT06204874Not ApplicableRecruitingPrimary

New Approaches to Nerve Stimulation Therapy for Bladder Pain Syndrome

NCT05658874Phase 3Terminated

A Multidisciplinary, Multimodal Bundled Care Approach to Chronic Pelvic Pain

NCT07459790Phase 2Recruiting

The Study is Being Conducted to Find a New Treatment for Patients Suffering From Interstitial Cystitis With Hunner's Lesions

NCT02591199Phase 2Terminated

Engage 24: Evaluation of the Safety and Effectiveness of URG101 in Subjects With Interstitial Cystitis/Bladder Pain Syndrome

NCT05127616Not ApplicableRecruiting

EPPIC: Easing Pelvic Pain Interventions Clinical Research Program

NCT06394830Phase 2Recruiting

Safety, Efficacy, and Frequency of Administration of VNX001 in the Treatment of Interstitial Cystitis / Bladder Pain Syndrome (IC/BPS)

NCT05737121Phase 2Recruiting

Safety and Efficacy Study of VNX001 Compared to Its Individual Components (Lidocaine and Heparin) or Placebo in Subjects With IC/BPS

NCT06299683Not ApplicableRecruiting

Pain Type and Interstitial Cystitis/Bladder Pain Syndrome Treatment

NCT06366269Not ApplicableRecruitingPrimary

Acupuncture First for IC/BPS

NCT00389142Recruiting

Identifying Genetic Causes of IC/BPS

NCT06212661Enrolling By Invitation

Migraine Medication Effects on Urinary Symptoms

NCT05699551Not ApplicableWithdrawn

Supervised Exercise as a Therapeutic Strategy for Interstitial Cystitis/Bladder Pain Syndrome

Scroll to load more

Research Network

Activity Timeline